Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
46 | Current Clinical Pharmacology | journal | 0.522 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
45 | Recent Patents on Drug Delivery and Formulation | journal | 0.203 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
44 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.405 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
43 | Current Metabolomics | journal | 0.288 Q3 | 4 | 0 | 9 | 0 | 10 | 8 | 0.83 | 0.00 | 0.00 | |
42 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.123 Q4 | 17 | 10 | 59 | 566 | 14 | 52 | 0.15 | 56.60 | 28.57 | |
41 | Current Enzyme Inhibition | journal | 0.153 Q4 | 19 | 20 | 61 | 698 | 26 | 54 | 0.34 | 34.90 | 50.00 | |
40 | Current Drug Therapy | journal | 0.138 Q3 | 20 | 14 | 56 | 678 | 24 | 51 | 0.53 | 48.43 | 26.19 | |
39 | Current Pharmacogenomics and Personalized Medicine | journal | 0.112 Q4 | 20 | 21 | 56 | 1270 | 6 | 50 | 0.16 | 60.48 | 33.96 | |
38 | Open Medicinal Chemistry Journal | journal | 0.237 Q2 | 23 | 12 | 22 | 455 | 24 | 22 | 1.26 | 37.92 | 42.86 | |
37 | Anti-Infective Agents | journal | 0.144 Q4 | 26 | 20 | 60 | 906 | 41 | 52 | 0.61 | 45.30 | 36.11 | |
36 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.284 Q3 | 27 | 12 | 63 | 452 | 63 | 56 | 0.88 | 37.67 | 39.53 | |
35 | Current Pharmaceutical Analysis | journal | 0.218 Q2 | 27 | 82 | 177 | 2329 | 119 | 168 | 0.70 | 28.40 | 47.71 | |
34 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.521 Q3 | 28 | 0 | 43 | 0 | 85 | 38 | 1.79 | 0.00 | 0.00 | |
33 | Current Bioactive Compounds | journal | 0.191 Q3 | 31 | 55 | 123 | 1960 | 80 | 110 | 0.66 | 35.64 | 36.92 | |
32 | Drug Metabolism Letters | journal | 0.312 Q2 | 31 | 20 | 74 | 622 | 64 | 65 | 0.88 | 31.10 | 46.05 | |
31 | Current Computer-Aided Drug Design | journal | 0.265 Q3 | 32 | 38 | 113 | 1534 | 109 | 95 | 1.03 | 40.37 | 31.20 | |
30 | Current Radiopharmaceuticals | journal | 0.299 Q3 | 32 | 31 | 81 | 1232 | 69 | 74 | 0.78 | 39.74 | 41.84 | |
29 | Reviews on Recent Clinical Trials | journal | 0.427 Q3 | 35 | 44 | 135 | 2311 | 131 | 120 | 1.00 | 52.52 | 38.38 | |
28 | Recent Patents on CNS Drug Discovery | journal | 0.290 Q3 | 36 | 0 | 27 | 0 | 36 | 23 | 1.11 | 0.00 | 0.00 | |
27 | Letters in Drug Design and Discovery | journal | 0.207 Q3 | 37 | 162 | 385 | 5795 | 335 | 381 | 0.93 | 35.77 | 42.26 | |
26 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 17 | 47 | 1568 | 78 | 43 | 2.18 | 92.24 | 39.68 | ||
25 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 24 | 68 | 1462 | 74 | 55 | 0.96 | 60.92 | 31.87 | ||
24 | Current Drug Safety | journal | 0.371 Q3 | 41 | 40 | 131 | 1071 | 158 | 120 | 1.27 | 26.78 | 41.88 | |
23 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 16 | 73 | 938 | 55 | 69 | 0.64 | 58.63 | 48.15 | ||
22 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.307 Q3 | 43 | 24 | 61 | 1300 | 55 | 52 | 1.03 | 54.17 | 26.67 | |
21 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.293 Q3 | 45 | 31 | 66 | 1834 | 76 | 61 | 1.00 | 59.16 | 20.24 | |
20 | Current Drug Discovery Technologies | journal | 0.397 Q3 | 49 | 32 | 72 | 1739 | 137 | 70 | 1.17 | 54.34 | 43.08 | |
19 | Current Molecular Pharmacology | journal | 0.774 Q2 | 49 | 34 | 99 | 2857 | 178 | 83 | 1.22 | 84.03 | 45.99 | |
18 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 30 | 111 | 1656 | 166 | 100 | 1.22 | 55.20 | 30.36 | ||
17 | Medicinal Chemistry | journal | 0.475 Q3 | 50 | 80 | 264 | 3667 | 485 | 256 | 1.78 | 45.84 | 43.20 | |
16 | Current Nanoscience | journal | 0.336 Q2 | 52 | 65 | 285 | 2563 | 407 | 259 | 1.51 | 39.43 | 33.33 | |
15 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.529 Q2 | 52 | 33 | 88 | 3586 | 192 | 82 | 2.10 | 108.67 | 50.97 | |
14 | Infectious Disorders - Drug Targets | journal | 0.351 Q3 | 61 | 34 | 83 | 1174 | 85 | 74 | 0.87 | 34.53 | 38.65 | |
13 | Current Vascular Pharmacology | journal | 0.605 Q2 | 69 | 106 | 251 | 7332 | 481 | 202 | 1.90 | 69.17 | 32.95 | |
12 | Combinatorial Chemistry and High Throughput Screening | journal | 0.367 Q3 | 70 | 95 | 287 | 3519 | 379 | 253 | 1.43 | 37.04 | 38.55 | |
11 | Current Drug Delivery | journal | 0.402 Q2 | 72 | 139 | 346 | 7811 | 572 | 325 | 1.54 | 56.19 | 46.49 | |
10 | Current Gene Therapy | journal | 1.008 Q1 | 80 | 41 | 139 | 3484 | 338 | 128 | 2.16 | 84.98 | 42.50 | |
9 | CNS and Neurological Disorders - Drug Targets | journal | 0.747 Q2 | 96 | 87 | 433 | 6391 | 937 | 373 | 2.32 | 73.46 | 36.21 | |
8 | Current Cancer Drug Targets | journal | 0.875 Q1 | 103 | 87 | 227 | 8117 | 521 | 202 | 2.15 | 93.30 | 41.22 | |
7 | Current Neuropharmacology | journal | 1.490 Q1 | 103 | 116 | 280 | 14411 | 1277 | 246 | 4.05 | 124.23 | 40.18 | |
6 | Mini-Reviews in Medicinal Chemistry | journal | 0.609 Q2 | 107 | 124 | 419 | 9892 | 1022 | 373 | 2.49 | 79.77 | 37.37 | |
5 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.528 Q3 | 108 | 218 | 518 | 13123 | 1043 | 487 | 1.91 | 60.20 | 41.37 | |
4 | Current Drug Targets | journal | 0.825 Q2 | 119 | 171 | 558 | 16711 | 1326 | 491 | 2.22 | 97.73 | 41.62 | |
3 | Current Topics in Medicinal Chemistry | journal | 0.878 Q1 | 133 | 242 | 775 | 22746 | 2415 | 671 | 3.09 | 93.99 | 41.81 | |
2 | Current Pharmaceutical Design | journal | 0.703 Q2 | 183 | 567 | 1815 | 57632 | 4871 | 1663 | 2.46 | 101.64 | 42.32 | |
1 | Current Medicinal Chemistry | journal | 0.918 Q1 | 202 | 332 | 835 | 40345 | 2886 | 780 | 3.22 | 121.52 | 45.73 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®